Sanjivani Paranteral
add_icon

Sanjivani Paranteral

219.00
+20.75
(10.47%)
Market Cap
₹- Cr
PE Ratio
-
Volume
12,298.00
Day High - Low
₹219.00 - ₹196.00
52W High-Low
₹396.95 - ₹170.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
36.49
EBITDA
-
Dividend Yield
- %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
neutral
Sanjivani Parenteral Limited reported revenue of INR 15.5 crores in Q2 FY26, down 14.5% year-on-year, primarily due to external disruptions including local unrest in Nepal affecting INR 1 crore worth of orders and tighter FDA scrutiny in Latin America slowing clearances. The company expects to start booking revenue from its SPL Infusion venture in Q3 FY26, with management projecting 10% minimum growth for the full year and targeting INR 150 crores revenue next year including contributions from the new IV plant.
negative
Sanjivani Parenteral Reports Decline in Q2 FY26 PerformanceNov 18, 2025
Sanjivani Parenteral Limited reported revenue from operations of INR 155.0 million for Q2 FY26, down 14.5% year-on-year, with EBITDA declining 25.7% to INR 24.1 million and PAT falling 28.6% to INR 16.4 million. The pharmaceutical company, which manufactures parenteral and oral solid products across multiple therapeutic areas, shared these results through an investor presentation highlighting performance for the quarter and half-year ended September 30, 2025.
negative
Sanjivani Parenteral Limited reported quarterly revenue decline of 14.5% YoY to Rs. 155.0 mn with PAT down 28.6% YoY to Rs. 16.4 mn, while maintaining EBITDA margin at 15.5%. The pharmaceutical company's injectables segment grew 2.4% YoY but oral segment declined 35.4% YoY due to shipment challenges, with exports contributing 81.6% of total revenue from core markets including CIS, Middle East Africa and Latin America.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
790.15
-
#1 -
-
-
-
-
34.61
699.20
-
#1 -
-
-
-
-
43.29
64.57
-
#1 -
-
-
-
-
21.03
554.80
-
#1 -
-
-
-
-
37.85
28,850.00
-
#1 -
-
-
-
-
39.24
42.05
-
#1 -
-
-
-
-
41.15
54.60
-
#1 -
-
-
-
-
42.72
5,001.00
-
#1 -
-
-
-
-
43.40
414.10
-
#1 -
-
-
-
-
43.97
26.95
-
#1 -
-
-
-
-
41.68
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
15
13
17
19
18
19
18
16
Expenses
13
11
14
15
15
16
15
13
EBITDA
2
2
2
3
3
3
3
2
Operating Profit %
13 %
17 %
14 %
16 %
15 %
14 %
15 %
15 %
Depreciation
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
Profit Before Tax
2
2
2
3
3
3
2
2
Tax
0
1
1
1
1
1
1
1
Net Profit
2
1
2
2
2
2
2
2
EPS in ₹
1.65
1.08
1.47
1.96
1.62
1.84
1.46
1.33

Balance Sheet

Balance Sheet
2024
2025
Total Assets
43
78
Fixed Assets
10
21
Current Assets
29
34
Capital Work in Progress
0
19
Investments
0
0
Other Assets
34
38
Total Liabilities
43
78
Current Liabilities
14
32
Non Current Liabilities
2
7
Total Equity
28
40
Reserve & Surplus
14
25
Share Capital
12
12

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
1
Investing Activities
-12
-22
Operating Activities
-11
12
Financing Activities
23
11

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
24.63 %
24.63 %
19.85 %
27.35 %
27.35 %
27.35 %
27.35 %
27.35 %
29.88 %
31.70 %
32.34 %
32.34 %
27.67 %
27.67 %
27.67 %
27.67 %
27.67 %
28.87 %
28.87 %
31.20 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
16.50 %
16.50 %
14.23 %
11.89 %
8.16 %
6.01 %
0.00 %
9.70 %
9.36 %
6.25 %
6.25 %
6.15 %
6.15 %
6.03 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
57.77 %
57.62 %
48.92 %
48.31 %
47.84 %
44.65 %
45.08 %
44.82 %
45.73 %
47.25 %
49.09 %
47.12 %
48.46 %
49.98 %
50.67 %
53.90 %
54.08 %
52.43 %
52.60 %
50.99 %
Others
17.61 %
17.75 %
31.23 %
24.33 %
24.80 %
28.00 %
11.07 %
11.33 %
10.16 %
9.16 %
10.42 %
14.53 %
23.87 %
12.65 %
12.31 %
12.18 %
11.99 %
12.54 %
12.38 %
11.78 %
No of Share Holders
4,952
4,911
4,829
5,004
4,974
4,848
4,826
4,845
4,887
4,758
4,500
4,499
4,800
4,911
6,166
6,731
6,618
6,447
6,429
6,307

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
18 Jan 2024 166.50 167.10
24 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2024 243.50 300.15
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 280.40 265.10
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 326.45 310.15
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 216.15 212.55
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 214.65 216.90
19 Sept 2025 DIVIDEND Dividend
₹ 0.50 /share
19 Sept 2025 212.55 239.45
26 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2025 216.90 239.90
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 208.85 202.00

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 18, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2025
Regulation 32 For The Quarter Ended 30Th September 2025Nov 14, 2025
Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 14, 2025
Board Meeting Outcome for Outcome Of The Second Quarter And Half Year Ended Financial Results Ended 31Th September 2025Nov 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2025
Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday 14Th November 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesOct 08, 2025
Closure of Trading WindowSep 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Announcement under Regulation 30 (LODR)-RetirementSep 19, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 11, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 11Th September 2025Sep 11, 2025
Disclosure Under Regulation 30Sep 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesSep 05, 2025
Intimation Of Record Date/Cut-Off Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 05, 2025
Reg. 34 (1) Annual Report.Sep 03, 2025
Notice Of 31St Annual General MeetingSep 03, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2025
Statement Of Deviation & Variation For The Quarter Ended 30Th June 2025Aug 12, 2025
Financial Results For The Quarter Ended 30Th June 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 12Th August 2025 Aug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Tuesday 12Th August 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 07, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 21, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesJul 18, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 18Th July 2025Jul 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Listing Approval For 197394 Equity Shares Issued On Preferential Basis Pursuant To Conversion Of WarrantsJul 05, 2025
Announcement under Regulation 30 (LODR)-AllotmentJul 04, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday04Th July 2025Jul 04, 2025
Closure of Trading WindowJun 24, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2025

Technical Indicators